Literature DB >> 6432858

The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals.

S J Gibson, J M Polak, J M Allen, T E Adrian, J S Kelly, S R Bloom.   

Abstract

The distribution of neuropeptide Y [NPY]-immunoreactive material was examined in the spinal cord and dorsal root ganglia of rat, guinea-pig, cat, marmoset, and horse. Considerable concentrations of NPY and similar distribution patterns of immunoreactive nerve fibres were found in the spinal cord of all species investigated. The dorsal root ganglia of the cat and the horse contained numerous immunoreactive nerve fibres, but in these species, as in the other three studied [rat, guinea-pig, marmoset], no positively stained cell bodies were found. Neuropeptide Y-immunoreactive nerves were observed at all levels of the spinal cord, being most concentrated in the dorsal horn. In the rat, guinea-pig, and marmoset, there was a marked increase of NPY-immunoreactive fibres in the lumbosacral regions of the spinal cord, and this was reflected by a considerable increase of extractable NPY. Estimations of NPY-immunoreactive material in the various regions of the rat spinal cord were as follows: cervical, 13.8 +/- 1.0; thoracic, 21.1 +/- 2.5; lumbar, 16.3 +/- 2.9; sacral, 92.4 +/- 8.5 pmol/gm wet weight of tissue +/- SEM. In the ventral portion of the guinea-pig spinal cord they were as follows: cervical, 7.1 +/- 1.2; thoracic, 8.2 +/- 3.6; lumbar, 22.6 +/- 7.0; sacral, 36.7 +/- 9.5 pmol/gm wet weight of tissue +/- SEM. Analysis of spinal cord extracts by reverse phase high performance liquid chromatography [HPLC] demonstrated that NPY-immunoreactive material elutes in the position of pure NPY standard. No changes in the concentration and distribution of the NPY-like material in the rat spinal cord were observed following a variety of surgical and pharmacological manipulations, including cervical rhizotomy, sciatic nerve section and ligation, and local application of capsaicin [50 mM] to one sciatic nerve. It is therefore suggested that most of the NPY-immunoreactive material in the spinal cord is derived either from intrinsic nerve cell bodies or from supraspinal tracts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432858     DOI: 10.1002/cne.902270109

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  28 in total

1.  Neuropeptide tyrosine (NPY) and its C-terminal flanking peptide (C-PON) in the developing and adult spinal cord of a reptile.

Authors:  E Marti; A R Bello; A Lancha; M A Batista
Journal:  J Anat       Date:  1990-10       Impact factor: 2.610

2.  Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide.

Authors:  T C Westfall; S P Han; M Knuepfer; J Martin; X L Chen; K del Valle; A Ciarleglio; L Naes
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

3.  Distribution and characterization of neuropeptide Y-like immunoreactivity in the brain and pituitary of the goldfish.

Authors:  A Pontet; J M Danger; P Dubourg; G Pelletier; H Vaudry; A Calas; O Kah
Journal:  Cell Tissue Res       Date:  1989       Impact factor: 5.249

4.  Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia.

Authors:  X Zhang; T Shi; K Holmberg; M Landry; W Huang; H Xiao; G Ju; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Reduced numbers of calcitonin gene-related peptide-(CGRP-) and tachykinin-immunoreactive sensory neurones associated with greater enkephalin immunoreactivity in the dorsal horn of a mutant rat with hereditary sensory neuropathy.

Authors:  S Kar; S J Gibson; F Scaravilli; J M Jacobs; V R Aber; J M Polak
Journal:  Cell Tissue Res       Date:  1989-02       Impact factor: 5.249

6.  Tonic inhibition of chronic pain by neuropeptide Y.

Authors:  Brian Solway; Soma C Bose; Gregory Corder; Renee R Donahue; Bradley K Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

7.  Orthopedic surgery modulates neuropeptides and BDNF expression at the spinal and hippocampal levels.

Authors:  Ming-Dong Zhang; Swapnali Barde; Ting Yang; Beilei Lei; Lars I Eriksson; Joseph P Mathew; Thomas Andreska; Katerina Akassoglou; Tibor Harkany; Tomas G M Hökfelt; Niccolò Terrando
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

8.  Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.

Authors:  Juan Carlos Marvizon; Wenling Chen; Weisi Fu; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-08-02       Impact factor: 5.250

9.  Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons.

Authors:  X Zhang; L Bao; Z Q Xu; J Kopp; U Arvidsson; R Elde; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain.

Authors:  A B Intondi; M N Dahlgren; M A Eilers; B K Taylor
Journal:  Pain       Date:  2007-10-31       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.